FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Cosette Pharmaceuticals' supplemental application for BENICAR (olmesartan medoxomil), resulting in labeling updates for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BENICAR (OLMESARTAN MEDOXOMIL)

Snippet

SUPPL AP for BENICAR (OLMESARTAN MEDOXOMIL)